title: Pneumocystis carinii jiroveci pneumonia following infliximab infusion for Crohn disease: emphasis on prophylaxis.
authors.forename: Kanan
authors.initials: K
authors.lastname: Sharma
authors.forename: Pallavi
authors.initials: P
authors.lastname: Rao
authors.forename: Padmini
authors.initials: P
authors.lastname: Krishnamurthy
authors.forename: Syed Ahsan
authors.initials: SA
authors.lastname: Ali
authors.forename: Gregory
authors.initials: G
authors.lastname: Beck
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000209:etiology* / Q000517:prevention & control
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab